Prostate Carcinoma
139
36
63
41
Key Insights
Highlights
Success Rate
77% trial completion
Published Results
14 trials with published results (10%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.6%
12 terminated out of 139 trials
77.4%
-9.2% vs benchmark
4%
6 trials in Phase 3/4
34%
14 of 41 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 41 completed trials
Clinical Trials (139)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization
Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study
Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer
Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation
To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy
An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
Massage for Prostate Cancer-Related Fatigue (mPROSTATE)
The Vanguard Study: Testing a New Way to Screen for Cancer
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer